c-myc oncogene expression in colorectal cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The c-myc oncogene plays a crucial role in cell proliferation and differentiation.
• Altered expression of c-myc is implicated in various cancers, including colorectal cancer.
• Understanding c-myc gene organization and expression is vital for cancer research.

Purpose of the Study:

• To investigate the organization and expression patterns of the c-myc gene in colorectal tumors.
• To correlate c-myc messenger ribonucleic acid (mRNA) levels with the abundance of its protein product, p62c-myc.
• To evaluate the potential of c-myc oncogene products as tumor markers for prognosis and treatment.

Main Methods:

• Analysis of c-myc gene organization using DNA hybridization in tumor and adjacent normal colon tissue.
• Quantification of c-myc mRNA transcripts via hybridization techniques.
• Detection and quantification of p62c-myc protein using immunoblotting and immunohistology with a specific monoclonal antibody.

Main Results:

• No evidence of c-myc gene amplification or rearrangement was found in the resected colonic tumors.
• c-myc mRNA transcripts were elevated up to 32-fold in 12 out of 15 tumors compared to normal colon tissue.
• A strong correlation was observed between c-myc mRNA levels and p62c-myc protein abundance, with variations noted based on tumor differentiation.

Conclusions:

• c-myc gene expression, specifically mRNA and protein levels, is frequently altered in colorectal tumors.
• The close correlation between c-myc mRNA and p62c-myc protein suggests a consistent regulatory mechanism.
• Assessing oncogene products like p62c-myc may offer valuable, biologically relevant tumor markers for improved patient prognosis and treatment guidance in colorectal cancer.